Suheung Co. Ltd. AI Stock Analysis
Want to see KR:008490 full AI Analyst Report?
Suheung Co. Ltd. (008490) AI Stock Analysis
Suheung Co. Ltd.
(Korea Exchange:008490)
The score is driven primarily by improving but mixed financial performance (strong TTM revenue growth and better leverage offset by margin compression and uneven cash conversion). Very cheap valuation (low P/E and solid dividend yield) provides meaningful support, while weak technicals (below key moving averages with negative MACD) meaningfully weigh on the overall score.
Suheung Co. Ltd. (008490) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- KRW 178.96B
- Dividend Yield
- 3.11%
- Average Volume (3M)
- 20.13K
- Price to Earnings (P/E)
- 4.8
- Beta (1Y)
- 0.12
- Revenue Growth
- 9.19%
- EPS Growth
- -6.51%
- Country
- KR
- Employees
- 769
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - Specialty & Generic
Suheung Co. Ltd. Business Overview & Revenue Model
Company Description
Suheung Co., Ltd. specializes in the production and provision of empty hard capsules, which are primarily utilized within the pharmaceutical and nutraceutical industries. The company further diversifies its business by offering comprehensive contract...
Suheung Co. Ltd. Financial Statement Overview
Summary
Strong TTM revenue rebound (+43.4%) and improving leverage (debt-to-equity down to ~0.75) support the score, but net margin has compressed (to 4.8%) and net income fell despite higher revenue. Cash flow is positive yet uneven, with weaker cash conversion and historical free-cash-flow volatility.
Income Statement
66PositiveBalance Sheet
62PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 769.23B | 722.31B | 653.26B | 594.57B | 634.97B | 596.73B |
| Gross Profit | 131.04B | 123.32B | 103.23B | 99.03B | 137.28B | 126.23B |
| EBITDA | 72.68B | 91.23B | 73.47B | 77.16B | 98.73B | 115.01B |
| Net Income | 36.95B | 43.49B | 18.28B | 6.12B | 33.98B | 53.69B |
Balance Sheet | ||||||
| Total Assets | 1.07T | 1.06T | 1.02T | 993.74B | 926.42B | 809.95B |
| Cash, Cash Equivalents and Short-Term Investments | 75.56B | 58.68B | 49.15B | 48.42B | 58.32B | 34.18B |
| Total Debt | 380.83B | 435.08B | 449.36B | 467.86B | 404.68B | 342.99B |
| Total Liabilities | 498.99B | 520.12B | 509.92B | 516.67B | 456.69B | 380.09B |
| Stockholders Equity | 509.80B | 488.68B | 454.68B | 425.67B | 421.34B | 387.76B |
Cash Flow | ||||||
| Free Cash Flow | 29.58B | 35.98B | 17.46B | -41.77B | -11.27B | 28.64B |
| Operating Cash Flow | 83.29B | 81.57B | 56.16B | 10.49B | 52.91B | 66.85B |
| Investing Cash Flow | -73.79B | -49.93B | -18.08B | -70.17B | -93.45B | -56.79B |
| Financing Cash Flow | -8.83B | -20.48B | -41.10B | 56.99B | 50.52B | -23.23B |
Suheung Co. Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:008490, the sentiment is Negative. The current price of 16070.00 is below the 20-day moving average (MA) of 17945.00, below the 50-day MA of 19425.20, and below the 200-day MA of 20344.10, indicating a bearish trend. The MACD of -690.78 indicates Positive momentum. The RSI at 24.51 is Positive, neither overbought nor oversold. The STOCH value of 24.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:008490.
Suheung Co. Ltd. Peers Comparison
Overall Rating
KR:03327071Outperform
KR:00550066Neutral- KR:00849063Neutral
KR:00431052Neutral
KR:00929052Neutral
KR:00352040Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| KR:033270 | 71Outperform | KRW 227.50B | 4.38 | ― | 3.91% | 0.85% | 25.23% |
| KR:005500 | 66Neutral | KRW 232.23B | 10.57 | ― | 4.05% | 0.28% | 16.80% |
| KR:008490 | 63Neutral | KRW 193.47B | 4.84 | ― | 3.11% | 9.19% | -6.51% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| KR:004310 | 52Neutral | KRW 200.96B | 53.87 | ― | 0.46% | 11.35% | 204.54% |
| KR:009290 | 52Neutral | KRW 297.76B | 24.73 | ― | 1.59% | 5.20% | -65.65% |
| KR:003520 | 40Underperform | KRW 141.56B | -18.48 | ― | ― | 1.83% | -860.41% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KR:008490 | Suheung Co. Ltd. | 16070.00 | -8640.26 | -34.97% | |
| KR:003520 | YUNGJIN PHARM. CO. LTD | 795.00 | -1245.00 | -61.03% | |
| KR:004310 | Hyundai Pharmaceutical Co., Ltd. | 6510.00 | 2734.53 | 72.43% | |
| KR:005500 | Samjin Pharmaceutical Co., Ltd. | 19760.00 | 483.01 | 2.51% | |
| KR:009290 | Kwang Dong Pharmaceutical Co., Ltd. | 6270.00 | 348.93 | 5.89% | |
| KR:033270 | KOREA UNITED PHARM, INC. | 15590.00 | -3735.87 | -19.33% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026